Utah Medical Products (UTMD) Reports Q4 EPS of $0.85
Tweet
Share
E-mailGet Alerts UTMD Hot Sheet
Join SI Premium – FREE
Utah Medical Products (NASDAQ: UTMD) reported Q4 EPS of $0.85, versus $0.80 reported last year. Revenue for the quarter came in at $9.58 million, versus $10.2 million reported last year.
For earnings history and earnings-related data on Utah Medical Products (UTMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
- Eikon Therapeutics, Inc. (EIKN) Misses Q2 EPS by 163c
- Inhibrx, Inc. (INBX) Misses Q2 EPS by 54c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
